Search results
A new COVID variant is dominant in the US: What are its symptoms?
TODAY via Yahoo News· 1 day agoThe new "FLiRT" COVID-19 variants, including KP.3 and KP.2, are spreading in the United States. Will...
2-in-1 shot for flu and COVID shows promise in advanced trial
Live Science via Yahoo News· 3 days agoPeople currently have to get their annual flu shots and updated COVID-19 vaccines separately. One...
AstraZeneca CFO: 'We've come a long way in our oncology portfolio'
Yahoo Finance· 17 hours agoAstraZeneca (AZN) has long been in the oncology and other disease spaces, but rose to popularity in...
Are We Headed for Another Summer COVID-19 Wave?
Time via Yahoo News· 1 day agoFor now, though, summer peaks seem to be happening not only because the virus is new and evolving, but also because immunity toCOVID-19 seems to wane...
Why 4 new bird flu developments have experts worried about the virus
Business Insider· 1 day agoThis story is available exclusively to Business Insider subscribers. Become an Insider and start...
Doctor: Diminished COVID-19 could present potential 'summer wave of sickness'
News 12· 5 days agoDr. Asha Shah, of Stamford Health, says that people continue to be hospitalized for the disease. "Usually the folks that are getting hospitalized, get the viral illness, they feel weak, they're ...
Moderna president: Company outlook 'stabilizing' thanks to new flu-COVID vaccine data
Yahoo Finance via AOL· 3 days agoModerna president Stephen Hoge knows investors are waiting to see the company grow in a big way and...
How personalized cancer vaccines could keep tumours from coming back
Nature· 3 days agoThe same mRNA technology that quickly brought the world a vaccine for COVID-19 is now showing...
3 Reasons to Buy Moderna Stock
Motley Fool via Yahoo Finance· 6 days agoAlthough Moderna (NASDAQ: MRNA) is now a somewhat famous biotech, it was a relatively unknown, clinical-stage company just five years ago. Its success in...
Why Moderna Stock Is a No-Brainer Buy Right Now
Motley Fool via Yahoo Finance· 4 days agoHere's why the biotech stock is a no-brainer buy right now. At an inflection point It's no exaggeration to say that Moderna is at an inflection point....